Skip to content

Triamcinolone

Aristocort, Kenacort (triamcinolone) is a small molecule pharmaceutical. Triamcinolone was first approved as Aristocort on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor.
Trade Name Aristocort, Kenacort
Common Name Triamcinolone
Indication adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, berylliosis, bronchial spasm, dermatitis herpetiformis, erythema multiforme, facial dermatoses, foot dermatoses, hand dermatoses, hemolytic anemia, hypercalcemia, inflammation, leg dermatoses, multiple sclerosis, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, scalp dermatoses, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
Drug Class Steroids (not prednisolone derivatives)
Triamcinolone
Get full access now